Sugar free, statistical copolymers made from at least three monomers

US10030089B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10030089-B2
Application numberUS-201414889290-A
CountryUS
Kind codeB2
Filing dateMay 6, 2014
Priority dateMay 6, 2013
Publication dateJul 24, 2018
Grant dateJul 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are polymers made from at least three monomers of formulae (I), (II), (III), and (IV) that may be used in pharmaceutical formulations. These polymers comprise a hydrocarbon backbone and are made from monomers that contain at least one carbon-carbon double bond. Methods of making the polymers are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymer having a backbone formed by reacting acrylate monomers with a free radical initiator in the presence of a chain transfer agent, wherein the polymer backbone consists of monomeric units derived from a monomer of formula I, a monomer of formula II, a monomer of formula III, and a monomer of formula IV, wherein formulae I-IV are: wherein at each occurrence, R 1 , R 2 and R 3 are independently H or methyl; R 4 is H or C 1 -C 6 alkyl; R 6 is C 1 -C 6 alkyl; and, the monomer of formula I is present in the backbone at a mole percent of from about 40-80; the monomer of formula II is present in the backbone at a mole percent of from about 5-20; the monomer of formula III is present in the backbone at a mole percent of from about 5-20; the monomer of formula IV is present in the backbone at a mole percent of from about 5-35. 2. A polymer according to claim 1 , wherein at least one occurrence of R 1 is H. 3. A polymer according to claim 1 , wherein at least one occurrence of R 2 is H. 4. A polymer according to claim 1 , wherein at least one occurrence of R 3 is H. 5. A polymer according to claim 1 , wherein R 6 is C 1 -C 4 alkyl. 6. A polymer according to claim 1 , wherein the monomer of formula (I) has the formula: 7. A polymer according to claim 1 , wherein the monomer of formula (II) has the formula: 8. A polymer according to claim 1 , wherein the monomer of formula (III) has the formula: or combinations thereof. 9. A polymer according to claim 1 , wherein the monomer of formula (IV) has the formula: or combinations thereof. 10. A polymer according to claim 1 , wherein the polymer is a statistical polymer. 11. A method of making the polymer of claim 1 , comprising treating the at least three monomers, with a free radical initiator in the presence of a chain transfer agent. 12. A method according to claim 11 , wherein the free radical initiator is AIBN. 13. A pharmaceutical formulation comprising the polymer of claim 1 , and at least one active pharmaceutical ingredient. 14. A method of increasing the solubility of a drug, the method comprising formulating the drug with the polymer of claim 1 . 15. A polymer according to claim 1 , wherein the mole percent of monomers of formula I in the polymer backbone is from about 43 to about 75. 16. A polymer according to claim 1 , wherein the mole percent of monomers of formula IV in the polymer backbone is from about 7 to about 30. 17. A polymer according to claim 1 , wherein the mole percent of monomers of formula I in the polymer backbone is from about 43 to about 75, and the mole percent of monomers of formula IV in the polymer backbone is from about 7 to about 30.

Assignees

Inventors

Classifications

  • and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate · CPC title

  • C08F220/28Primary

    containing no aromatic rings in the alcohol moiety · CPC title

  • Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

  • Chemistry & Metallurgy · mapped topic

  • and containing one or more carboxylic moiety in the chain, e.g. acetoacetoxyethyl(meth)acrylate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10030089B2 cover?
Disclosed herein are polymers made from at least three monomers of formulae (I), (II), (III), and (IV) that may be used in pharmaceutical formulations. These polymers comprise a hydrocarbon backbone and are made from monomers that contain at least one carbon-carbon double bond. Methods of making the polymers are also disclosed.
Who is the assignee on this patent?
Univ Minnesota, The Regents Of The Univ Of Minnesota
What technology area does this patent fall under?
Primary CPC classification C08F220/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).